Insights / Members-only Leveraging RWE early is critical for emerging biopharma companies Barbara Arone, vice president, real world solutions, IQVIA, examines the ways biotech and emerging biopharma companies can effectively apply real world evidence (RWE) early in the product lifecycle while staying within their resource limits. By Barbara Arone / 3 Mar 2023
